BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21215162)

  • 1. [Differences between clinical response and pathologic response of breast cancer after neoadjuvant chemotherapy].
    Zheng S; Zhang BL; Zhang RZ; Yang JL; Zou SM; Xue LY; Luo W; Yuan YL; Lü N
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):734-8. PubMed ID: 21215162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy].
    Zheng S; Zhang BL; Xiao T; Zou SM; Xue LY; Luo W; Guo L; Liu XY; Lü N
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):465-70. PubMed ID: 22088373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].
    Li D; Chen JH; Wang J; Ling R; Yao Q; Wang L
    Ai Zheng; 2007 Aug; 26(8):900-4. PubMed ID: 17697556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.
    Li P; Liu T; Wang Y; Shao S; Zhang W; Lv Y; Yi J; Wang Z
    Clin Breast Cancer; 2013 Feb; 13(1):53-60. PubMed ID: 23103368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
    McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G
    Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer.
    Adrada BE; Huo L; Lane DL; Arribas EM; Resetkova E; Yang W
    Ann Surg Oncol; 2015 Apr; 22(4):1111-7. PubMed ID: 25287438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS; Apple SK
    Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of DCE-MRI for early evaluation of pathological complete response to neoadjuvant chemotherapy in resectable primary breast cancer: A single-center prospective study.
    Sun YS; He YJ; Li J; Li YL; Li XT; Lu AP; Fan ZQ; Cao K; Ouyang T
    Breast; 2016 Dec; 30():80-86. PubMed ID: 27652977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sonographic criteria for the differentiation of benign and malignant breast lesions using real-time spatial compound imaging in combination with XRES adaptive image processing].
    Hahn M; Roessner L; Krainick-Strobel U; Gruber IV; Krämer B; Gall C; Siegmann KC; Wallwiener D; Kagan KO
    Ultraschall Med; 2012 Jun; 33(3):270-4. PubMed ID: 20614412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of clinico-pathologic and radiologic parameters of response to neoadjuvant chemotherapy in breast cancer.
    Mukherjee P; Sharma S; Sheikh ZA; Vijaykumar DK
    Indian J Cancer; 2014; 51(1):25-9. PubMed ID: 24947092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphologic assessment of response to neoadjuvant chemotherapy in breast cancer].
    Zheng S; Zhang BL; Zou SM; Lin DM; Xue LY; Luo W; Yuan YL; Lü N
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):18-22. PubMed ID: 19489220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiologic-histopathologic correlation of microcalcifications from 11g vacuum biopsy: analysis of 3196 core biopsies].
    Fischmann A; Pietsch-Breitfeld B; Müller-Schimpfle M; Siegmann K; Wersebe A; Rothenberger-Janzen K; Claussen CD; Janzen J
    Rofo; 2004 Apr; 176(4):538-43. PubMed ID: 15088178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.
    Tanioka M; Sasaki M; Shimomura A; Fujishima M; Doi M; Matsuura K; Sakuma T; Yoshimura K; Saeki T; Ohara M; Tsurutani J; Watatani M; Takano T; Kawabata H; Mukai H; Naito Y; Hirokaga K; Takao S; Minami H
    Breast; 2014 Aug; 23(4):466-72. PubMed ID: 24742606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience of automated breast volume scanning (ABVS) and ultrasound elastography in predicting breast cancer subtypes and staging.
    Wang XL; Tao L; Zhou XL; Wei H; Sun JW
    Breast; 2016 Dec; 30():130-135. PubMed ID: 27718417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
    Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
    Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
    Peintinger F; Kuerer HM; Anderson K; Boughey JC; Meric-Bernstam F; Singletary SE; Hunt KK; Whitman GJ; Stephens T; Buzdar AU; Green MC; Symmans WF
    Ann Surg Oncol; 2006 Nov; 13(11):1443-9. PubMed ID: 17028770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of response evaluation methods of neoadjuvant chemotherapy in breast cancer patients].
    Sun B; Song ST; Wu SK; Jiang ZF; Wang T; Zhang SH; Zhao YB; Yu CZ; Li XB; Yang T; Li GJ
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):783-5. PubMed ID: 20021835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study.
    Fornage BD; Sneige N; Ross MI; Mirza AN; Kuerer HM; Edeiken BS; Ames FC; Newman LA; Babiera GV; Singletary SE
    Radiology; 2004 Apr; 231(1):215-24. PubMed ID: 14990810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.